Back to mobile site

Morgan Stanley Starts Medline Inc (MDLN) at Overweight

January 12, 2026 3:16 AM EST Send to a Friend
Morgan Stanley analyst Patrick Wood initiates coverage on Medline Inc (NASDAQ: MDLN) with a Overweight rating and a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login